[HTML][HTML] Update on pulmonary disease due to non-tuberculous mycobacteria
Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of
chronic pulmonary infection, posing a number of challenges for both clinicians and …
chronic pulmonary infection, posing a number of challenges for both clinicians and …
Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis
Bronchiectasis is a disease associated with chronic progressive and irreversible dilatation of
the bronchi and is characterised by chronic infection and associated inflammation. The …
the bronchi and is characterised by chronic infection and associated inflammation. The …
Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis
Objective To accurately estimate the global prevalence of non-tuberculous mycobacteria
(NTM) in adults with non-cystic fibrosis (non-CF) bronchiectasis and to determine the …
(NTM) in adults with non-cystic fibrosis (non-CF) bronchiectasis and to determine the …
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
J Park, J Cho, CH Lee, SK Han… - Clinical Infectious …, 2017 - academic.oup.com
Abstract Background Mycobacterium abscessus and Mycobacterium massiliense are
grouped as the Mycobacterium abscessus complex. The aim of this study was to elucidate …
grouped as the Mycobacterium abscessus complex. The aim of this study was to elucidate …
[HTML][HTML] Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients
K Dimakou, C Triantafillidou, M Toumbis… - Respiratory …, 2016 - Elsevier
Abstract Background and objectives Non-Cystic Fibrosis (CF) bronchiectasis is common in
Greece but little attention has been paid to the investigation of its aetiology, clinical …
Greece but little attention has been paid to the investigation of its aetiology, clinical …
Pulmonary disease by non-tuberculous mycobacteria–clinical management, unmet needs and future perspectives
LO Larsson, E Polverino, W Hoefsloot… - Expert review of …, 2017 - Taylor & Francis
Introduction: The number of patients with pulmonary disease caused by non-tuberculous
mycobacteria (NTM) is increasing globally. Poor resistance against infections, for example …
mycobacteria (NTM) is increasing globally. Poor resistance against infections, for example …
Protease–Antiprotease imbalance in bronchiectasis
Airway inflammation plays a central role in bronchiectasis. Protease–antiprotease balance is
crucial in bronchiectasis pathophysiology and increased presence of unopposed proteases …
crucial in bronchiectasis pathophysiology and increased presence of unopposed proteases …
[HTML][HTML] Characterizing non-tuberculous mycobacteria infection in bronchiectasis
P Faverio, A Stainer, G Bonaiti, SC Zucchetti… - International journal of …, 2016 - mdpi.com
Chronic airway infection is a key aspect of the pathogenesis of bronchiectasis. A growing
interest has been raised on non-tuberculous mycobacteria (NTM) infection. We aimed at …
interest has been raised on non-tuberculous mycobacteria (NTM) infection. We aimed at …
Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics
P Faverio, F De Giacomi, BD Bodini… - ERJ Open …, 2021 - Eur Respiratory Soc
Nontuberculous mycobacterial (NTM) pulmonary disease (PD) is an emerging condition with
heterogeneous manifestations from both the microbiological and the clinical point of view …
heterogeneous manifestations from both the microbiological and the clinical point of view …
New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes
Background The close association between bronchiectasis and nontuberculous
mycobacterial pulmonary disease (NTM-PD) is well-known. However, the clinical impact of …
mycobacterial pulmonary disease (NTM-PD) is well-known. However, the clinical impact of …